Insurance reimbursement of imported drugs on rejection movement

Both of foreign pharmaceutical and local drug import trading company strongly backlashed against the government insurance reimbursement plan for imported drugs which already reflected overall price slash when assessing the reimbursement price authorization recently even before executing the government impending price cut program for all domestic drugs in line with the implementation of the medi...